StonvexLoading…
StonvexStonvexStonvexCore line items from PAYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $26.88M | $28.04M | $82.03M | $59.27M | $37.68M |
Operating Income | Not available | $6.67M | $7.36M | $5.51M | $3.93M |
Net Income | Not available | $5.44M | $7.55M | $6.19M | $1.39M |
EPS (Diluted) | $0.06 | $0.09 | $0.13 | $0.10 | $0.07 |
Total Assets | Not available | $312.73M | $276.25M | $209.51M | $193.90M |
Total Liabilities | Not available | $257.71M | $227.76M | $163.75M | $151.69M |
Cash & Equivalents | Not available | $179.50M | $164.98M | $118.55M | $113.91M |
Free Cash Flow OCF − CapEx | Not available | $18.52M | $51.24M | $3.74M | $-2.56M |
Shares Outstanding | Not available | 55.74M | 55.09M | 55.04M | 54.41M |